CERULOPLASMIN - ANVISA Registration 10350840067
Access comprehensive regulatory information for CERULOPLASMIN in Brazil's medical device market through Pure Global AI's free database. This Risk Class II medical device is registered under ANVISA number 10350840067 and manufactured by APTEC DIAGNOSTICS. The registration is held by BIOSYS LTDA with validity until currently active (VIGENTE).
This page provides complete technical specifications for this device, regulatory compliance details, 5 companies making the same product including ROCHE DIAGNOSTICS GMBH, SENTINEL CH. SPA, and 5 recent registrations in the same technical category. Pure Global AI offers free access to over 100,000+ Brazilian medical device registrations, helping global MedTech companies navigate ANVISA regulations, identify competitors, and discover partnership opportunities efficiently.
Device Details
Registration Details
10350840067
250000217569918
02220795000179
Company Information
Dates and Status
Jan 10, 2000
VIGENTE
09/18/2025 19:00:01
ROCHE DIAGNOSTICS GMBHโข Germany
SENTINEL CH. SPAโข Italy
DAKO DENMARK A/S - DINAMARCA PARA ROCHE DIAGNOSTICS GMBHโข Germany
BECKMAN COULTER INCโข United States of America
BECKMAN COULTER, INC.โข United States of America
CERULOPLASMINA
Ceruloplasmina
VYTTRA DIAGNOSTICOS S.A.
81692610214
Dec 10, 2020
CERULOPLASMINA
Ceruloplasmina Reagente
SIEMENS HEALTHCARE DIAGNOSTICS, INC. - EUA
10345162354
Apr 06, 2020
CERULOPLASMINA
Alinity c Ceruloplasmin Reagent Kit
SENTINEL CH. SPA
80146502245
Feb 26, 2020
CERULOPLASMINA
CERU (Ceruloplasmin)_cobas c
ROCHE DIAGNOSTICS GMBH
10287411469
Jan 27, 2020
CERULOPLASMINA
Optilite Caeruloplasmin Kit
THE BINDING SITE GROUP LTD
81357320027
Nov 20, 2017

